期刊文献+

基于gyrB基因建立快速检测沙雷菌的PCR方法 被引量:3

Rapid detection of Serratia spp. by PCR using the primers targeting the gyrB gene
原文传递
导出
摘要 选择gyr B基因作为靶基因设计特异性引物用于沙雷菌属的PCR检测,该特异性引物扩增产物的片段大小为279 bp。研究所选用的14株沙雷菌分别代表沙雷菌属的7个不同种。此外,2种沙门菌、2种克雷伯菌以及其他5种肠道菌用于进行引物特异性的验证。结果表明:扩增的条带与预期的扩增产物片段大小一致,而非沙雷菌属的其他9个种属均没有扩增条带;该方法检测沙雷菌的最低检测限为9.785 pg。通过对4株从蜜蜂中分离所得的黏质沙雷菌和3株从进口鱼粉中分离所得的居泉沙雷菌进行检测,结果均为阳性。研究表明,基于gyr B基因建立的PCR方法在沙雷菌属的检测中具有特异性强、快速和灵敏度高等特点。 A species-specific primer pair was designed for the PCR detection of Serratia spp. using gyr B gene as the target gene with the fragment size of 279 bp. Fourteen members of the Serratia family( representing seven Serratia species) were chosen to verify the specificity of the primers. Additionally,two species from Salmonella,two from Klebsiella,and five other species belonging to five other genera of Enterobacteriaceae,were tested for primer cross-reaction,and all the tested strains gave negative results. The limit of detection for Serratia genomic DNA using the gyr B gene was 9. 785 pg per PCR reaction. Four clinical samples from bees and three clinical samples from imported fish meal were detected,and all clinical samples showed positive results. This PCR assay provides a specific,rapid,and sensitive method to detect Serratia species based on their gyr B gene.
出处 《畜牧与兽医》 北大核心 2017年第7期103-108,共6页 Animal Husbandry & Veterinary Medicine
基金 国家自然科学基金(31272606) 国家质检总局科技计划项目(2016IK030) 福建检验检疫局科技计划项目(FK2015-JS002)
关键词 沙雷菌 肠道菌 gyrB基因 PCR Serratia spp Enterobacteriaceae gyrB gene PCR
  • 相关文献

参考文献3

二级参考文献32

  • 1周田美,董晓勤,俞云松,王杰,余道军,周志慧.沙雷菌属耐药现状及β-内酰胺酶检测[J].中华医院感染学杂志,2005,15(1):103-105. 被引量:12
  • 2王贺,徐英春,陈民钧.细菌质粒介导的喹诺酮类抗菌药物耐药机制研究进展[J].中华医院感染学杂志,2007,17(5):618-620. 被引量:151
  • 3Clinical and Laboratory Standards Institute.Performance standardsfor antimicrobial susceptibility testing,nineteenth informationalsupplement[S].M100-S19.CLSI,2009.
  • 4Clinical and Laboratory Standards Instiute. Performance stand-ards for antimicrobial susceptibility testing; Twentieth informa. tional supplement. CLSI/NCCLS document M100 S20[R. Penn- syivania:Clinical and Laboratory Standards Instiute. Clinical and Laboratory Standards Instiute,2010,20- 143.
  • 5Schmidtke A J,Hanson N D. Model system to evaluate the eect of ampD mutations On ampC mediated beta-laetam resistance [J]. Antimicrob Agents Chemother,2006,50(6):2030.
  • 6Samonis G, Vouloumanou EK, Christofaki M, et al. Serratia in- fections in a general hospital: characteristics and outcomes [ J ]. Eur J Clin Microbiol Infect Dis, 2011, 30(5) : 653-660.
  • 7Zhang R, Cai JC, Zhou HW, et al. Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapen- ems[J]. J Med Micrebiol, 2011, 60(Pt 12) : 1813-1819.
  • 8Mataseje LF, Boyd DA, Delport J, et al. Serratia marcescens har- bouring SME-type class A carbapenemases in Canada and the pres- ence of blasMg on a novel genomic island, SmarGIl-1 [J]. J Anti- microb Chemother, 2014, 69(7): 1825-1829.
  • 9Dalvi SD, Worobec EA. Gene expression analysis of the SdeAB multidrug efflux pump in antibiotic-resistant clinical isolates of Ser- ratia marcescens [ J]. Indian J Med Micrebiol, 2012, 30 ( 3 ) : 302-307.
  • 10Zhang R, Zhou HW, Cai JC, et al. Plasmid-mediated carbapen- em-hydrolysing beta-lactamase KPC-2 in carbapenem-resistant Ser- ratia rnarcescer isolates from Hangzhou, China[J]. J Antimicrob Chemother, 2007, 59(3): 574-576.

共引文献20

同被引文献15

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部